Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington School of Medicine, Seattle, Washington, USA.
Communicable Disease Epidemiology and Immunization Section, Public Health-Seattle & King County, Seattle, Washington, USA.
Clin Infect Dis. 2024 May 15;78(5):1214-1221. doi: 10.1093/cid/ciae094.
Nontoxigenic Corynebacterium diphtheriae, often associated with wounds, can rarely cause infective endocarditis (IE). Five patients with C. diphtheriae IE were identified within 12 months at a Seattle-based hospital system. We reviewed prior C. diphtheriae-positive cultures to determine if detections had increased over time and evaluated epidemiologic trends.
We conducted a formal electronic health record search to identify all patients aged ≥18 years with C. diphtheriae detected in a clinical specimen (ie, wound, blood, sputum) between 1 September 2020 and 1 April 2023. We collected patient demographics, housing status, comorbidities, substance-use history, and level of medical care required at detection. We extracted laboratory data on susceptibilities of C. diphtheriae isolates and on other pathogens detected at the time of C. diphtheriae identification.
Between 1 September 2020 and 1 April 2023, 44 patients (median age, 44 years) had a C. diphtheriae-positive clinical culture, with most detections occurring after March 2022. Patients were predominantly male (75%), White (66%), unstably housed (77%), and had a lifetime history of injecting drugs (75%). Most C. diphtheriae-positive cultures were polymicrobial, including wound cultures from 36 (82%) patients and blood cultures from 6 (14%) patients, not mutually exclusive. Thirty-four patients (77%), including all 5 patients with C. diphtheriae IE, required hospital admission for C. diphtheriae or a related condition. Of the 5 patients with IE, 3 died of IE and 1 from COVID-19.
Findings suggest a high-morbidity outbreak disproportionately affecting patients who use substances and are unstably housed.
非产毒株白喉棒状杆菌常与伤口有关,但很少引起感染性心内膜炎(IE)。在西雅图的一家医院系统中,在 12 个月内发现了 5 例白喉棒状杆菌 IE 患者。我们回顾了之前的白喉棒状杆菌阳性培养物,以确定检测是否随时间增加,并评估了流行病学趋势。
我们进行了正式的电子病历搜索,以确定 2020 年 9 月 1 日至 2023 年 4 月 1 日期间在临床标本(即伤口、血液、痰液)中检测到的≥18 岁的所有白喉棒状杆菌患者。我们收集了患者的人口统计学、住房状况、合并症、药物使用史以及在检测时所需的医疗水平。我们提取了关于白喉棒状杆菌分离株的药敏性和在白喉棒状杆菌鉴定时同时检测到的其他病原体的数据。
2020 年 9 月 1 日至 2023 年 4 月 1 日期间,44 例患者(中位年龄 44 岁)的临床培养物呈白喉棒状杆菌阳性,大多数检测发生在 2022 年 3 月之后。患者主要为男性(75%)、白人(66%)、住房不稳定(77%),且有终身药物注射史(75%)。大多数白喉棒状杆菌阳性培养物为混合感染,包括 36 例(82%)患者的伤口培养物和 6 例(14%)患者的血液培养物,并非相互排斥。34 例(77%)患者,包括 5 例白喉棒状杆菌 IE 患者,因白喉棒状杆菌或相关疾病需要住院治疗。在 5 例 IE 患者中,有 3 例死于 IE,1 例死于 COVID-19。
研究结果表明,这是一场发病率较高的疫情,主要影响使用药物和住房不稳定的患者。